![](https://endpts.com/wp-content/uploads/2021/02/Jeremy-Bender-Day-One-Biopharmaceuticals-tile-scaled.jpg)
Jeremy Bender, Day One Biopharmaceuticals CEO
Day One Biopharmaceuticals inks research collaboration with Swedish biotech
Day One Biopharmaceuticals secured a research and licensing deal with Sprint Bioscience in a bid to build out its cancer-fighting arsenal.
The Bay Area biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.